# Efficacy of Selegiline in Negative Symptoms of Schizophrenia

> **NCT00456976** · EARLY_PHASE1 · COMPLETED · sponsor: **Tabriz University** · enrollment: 70 (—)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Selegiline

## Key facts

- **NCT ID:** NCT00456976
- **Lead sponsor:** Tabriz University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 70 (—)
- **Last updated:** 2008-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00456976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00456976, "Efficacy of Selegiline in Negative Symptoms of Schizophrenia". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00456976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*